The guest lecture focuses on personalized cancer vaccines and Dr Özlem Türeci describes the content of this lecture as follows:
“My talk at the University will be a scientific, technological one directed to an expert scientific and clinical audience with strong background in immunology and oncology. I may cover 2 topics if time allows: preclinical-clinical development of RNA cancer vaccines and a new CAR T cell”.
This event requires registration. Please register here!
For more background information on cancer vaccines:
Dr Özlem Türeci will on November 16 also give a second talk at The Norwegian Academy of Science and Letters on the development of the mRNA vaccine technology and the journey from cancer vaccines to the Pfizer/BioNTech Covid vaccines: "Vaccines: mRNA vaccine technology - Cancer, COVID-19 & beyond".